by John R. Fischer
, Senior Reporter | September 16, 2021
Edward Rodriguez, a clinical advisor with symplr, said in June that demand for CT was also picking up in the nuclear medicine market
, with 20% of providers showing interest in PET/CT and 18% in both nuclear medicine CT and specialty systems. This, he says, will help the molecular imaging market reach $5.855 billion by 2025. “Previously, nuclear medicine systems have been the second most frequent quotes submitted by our client members for analysis. However, in the last 12 months PET/CT has been the second most active, including both the 16 to 40 and 64 to 128-slice supplier solutions.”
Frost & Sullivan sees both traditional and mobile CT increasing in use, with mobile increasing the number of participants in the market. Top manufacturers that offer a broad range of CTs will especially benefit, it says. Reimbursement approval from current CPT and European regulations are expected to push CT into the cardiac realm. Mayo Clinic in Rochester, in fact, recently performed the first cardiac scan with a new photon-counting detector CT
. With it, providers were able to see clear images of the heart and blood vessels, and could even capture a small fraction of one heartbeat by "freezing" the motion.
For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
And while low-end CT has achieved its maximum penetration potential in developed economies, demand for them still exists in developing economies, according to Srinivasan. "Emerging countries in Eastern Europe, South Africa, LATAM and tier III cities in India and Indonesia will continue to influence the purchase of 6- or 8-slice CT scanners. The potential for single and dual slice scanners will be obsolete or negligible in the region."
Additional clinical applications are expected to emerge in vascular, oncology and breast cancer imaging, according to Frost & Sullivan. Back to HCB News